PHR
Phreesia Inc.
$20.46
+$1.41(+7.40%)
40
Overall
50
Value
30
Tech
--
Quality
Market Cap
$1.33B
Volume
675.27K
52W Range
$17.78 - $32.76
Target Price
$33.60
Company Overview
| Mkt Cap | $1.33B | Price | $20.46 |
| Volume | 675.27K | Change | +7.40% |
| P/E Ratio | -22.8 | Open | $19.27 |
| Revenue | $419.8M | Prev Close | $19.05 |
| Net Income | $-58.5M | 52W Range | $17.78 - $32.76 |
| Div Yield | N/A | Target | $33.60 |
| Overall | 40 | Value | 50 |
| Quality | -- | Technical | 30 |
No chart data available
Latest News
PharmaTher Secures Rights to Long-Acting Ketamine Program for Neuropsychiatric Disorders
TipRanks Canadian Auto-Generated Newsdesk•5 days ago
Starpharma Announces Successful 2025 AGM Results
TipRanks Australian Auto-Generated Newsdesk•8 days ago
Phreesia Secures $110 Million Loan for Acquisition
TipRanks Auto-Generated Newsdesk•9 days ago
Stifel Nicolaus Remains a Buy on Cipher Pharmaceuticals (CPHRF)
TipRanks Auto-Generated Intelligence Newsdesk•12 days ago
Water Intelligence PLC Executes Share Buyback to Optimize Capital Structure
TipRanks UK Auto-Generated Newsdesk•16 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PHR | $20.46 | +7.4% | 675.27K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |